MK0429 Study in Prostate Cancer Patients With Metastatic Bone Disease (0429-011)
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
This two part study will evaluate the safety and tolerability of MK0429 in addition to
assessing it's pharmacokinetic profile and pharmacodynamic response.